(Q54798865)

3 June 2018

title

High-throughput screening and biophysical interrogation of hepatotropic AAV. (English)

1 reference

3 June 2018

author name string

Samuel L Murphy

1

1 reference

3 June 2018

Anand Bhagwat

2

1 reference

3 June 2018

Shyrie Edmonson

3

1 reference

3 June 2018

Shangzhen Zhou

4

1 reference

3 June 2018

Katherine A High

5

1 reference

3 June 2018

publication date

30 September 2008

1 reference

3 June 2018

published in

Molecular Therapy

1 reference

3 June 2018

volume

16

1 reference

3 June 2018

issue

12

1 reference

3 June 2018

page(s)

1960-1967

1 reference

3 June 2018

Treatment of human disease by adeno-associated viral gene transfer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

New recombinant serotypes of AAV vectors.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Adeno-associated virus serotypes: vector toolkit for human gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Novel tools for production and purification of recombinant adenoassociated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

How adeno-associated virus Rep78 protein arrests cells completely in S phase

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

CDK2/cyclinA inhibitors: targeting the cyclinA recruitment site with small molecules derived from peptide leads

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Liver cell lines for the study of hepatocyte functions and immunological response

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Identification of PDGFR as a receptor for AAV-5 transduction

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Gene therapy for haemophilia

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Adeno-associated virus vectors can be efficiently produced without helper virus

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.210

7 January 2021

Identifiers

DOI

10.1038/MT.2008.210

1 reference

3 June 2018

PubMed ID

18827805

1 reference

3 June 2018